Evaluation of four Narcissus Cultivars as potential sources for galanthamine production

Planta Medica

Volumn 63, Issue 5, 1997, Pages 473-474

  Moraes Cerdeira, Rita M ^a   Burandt Jr , Charles L ^a   Bastos, Jairo K ^a   Nanayakkara, N P Dhammika ^a   Mikell, Julie ^a   Thurn, Jeffrey ^a   McChesney, James D ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b NaPro BioTherapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALANTAMINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CULTIVAR; DRUG ISOLATION; NARCISSUS; PLANT GROWTH; ALZHEIMER DISEASE; CLASSIFICATION; HUMAN; ISOLATION AND PURIFICATION; LETTER; MEDICINAL PLANT; METABOLISM; PLANT ROOT;

AMARYLLIDACEAE; NARCISSUS; NARCISSUS PSEUDONARCISSUS;

ALZHEIMER DISEASE; GALANTAMINE; HUMANS; PLANT ROOTS; PLANTS, MEDICINAL;

EID: 0031253157     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-957740     Document Type: Article

References (6)

1. Davis, B. (1987) Method of treating Alzheimer's disease. U. S. Patent 4663318 (CL 514-215:A61K31/55).
2. Schoenberg, B. S., Kokmen, E., Okazaki, H. (1987) Ann. Neurol. 22, 724-729.
3. Bastos, J. K., Xu Li, Nanayakkara, N. P. D., Burandt, C. L., Moraes-Cerdeira, R. M., and McChesney, J. D. (1996) J. Nat. Prod. 59, 638-640.
4. SAS Institute (1988). SAS/STAT user's guide. Release 6.03 ed. SAS Inst., Cary, N. C.
5. Rees, A. R. (1973) Acta Hort. 47, 391-396.
6. Anderson, L. (1989) Amer. Hort. 2, 21-22.